SIG INVESTOR ALERT: The Law Offices of Vincent Wong

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SIG INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Signet Jewelers Limited and a Lead Plaintiff Deadline of October 24, 2016

NEW YORK, Sept. 02, 2016 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Signet Jewelers Limited (NYSE: SIG ) securities between January 7, 2016 and June 3, 2016.

Click here to learn about the case: http://www.wongesq.com/pslra/signet-jewelers-limited . There is no cost or obligation to you.

According to the complaint, throughout the Class Period defendants issued false and misleading statements and/or failed to disclose that: (1) Signet was experiencing difficulty ensuring the safety of customers’ jewelry while in the custody of Signet’s brands; (2) Signet’s employees at stores under at least one of Signet’s brands (Kay) were swapping customers’ stones for less valuable stones; (3) Signet was experiencing a decrease in customer confidence; (4) Signet had increasing competitive pressures; and (5) consequently, Signet’s financial performance was being negatively impacted.

If you suffered a loss in Signet you have until October 24, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com , by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/signet-jewelers-limited .

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: vw@wongesq.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nokia Corporation's Recent Management Transaction Highlights

Updated Category News Views 135

Nokia Corporation's Latest Management Transactions Nokia Corporation has recently announced significant management transactions that emphasize its ongoing operational strategies and technological innovations. Today, we dive into the details of one particular transaction involving a key manager in the company. Transaction Details This transaction notification is made under...

Continue Reading
Huawei's Innovative AI WAN Solution Revolutionizes Networking

Updated Category News Views 262

Huawei's New AI WAN Solution Unveiled At the Mobile World Congress in Barcelona, Huawei introduced the AI WAN Solution, a groundbreaking development designed to revolutionize networking. Leon Wang, the President of Huawei's Data Communication Product Line, emphasized the importance of merging AI with network infrastructures. This new solution aims to enhance IP networks...

Continue Reading
Transforming Business Dreams with Innovative Software Solutions

Updated Category News Views 114

Transforming Business Dreams with Innovative Software Solutions FM, a pioneer in custom software development augmented by AI technology, is revolutionizing how businesses approach growth and scalability. In a rapidly changing landscape, where adaptability is key, FM’s approach enables organizations to leverage generative software solutions that are more accessible than...

Continue Reading
Investment in Caesars Palace Times Square Promises Growth

Updated Category News Views 171

Community Investment and Support for Caesars Palace Times Square During a recent public hearing, community support was overwhelmingly evident for the Caesars Palace Times Square project. Local residents, small business owners, union workers, and city leaders gathered to express their enthusiasm for a project that promises to generate significant economic growth and create...

Continue Reading
Aquestive Therapeutics Reaches Milestone with FDA Notification

Updated Category News Views 114

Groundbreaking News from Aquestive Therapeutics Aquestive Therapeutics, Inc. (NASDAQ: AQST), a forward-thinking pharmaceutical company dedicated to enhancing patient care through innovative drug delivery solutions, has officially received word from the U.S. Food and Drug Administration (FDA) that no advisory committee meeting will be required for the New Drug Application...

Continue Reading